The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and...

Area of Science:

• Pharmacology and Public Health
• Telemedicine and Behavioral Science

Background:

• Hypertension, hyperlipidemia, and diabetes are key modifiable risk factors for cardiovascular disease (CVD).
• Nonadherence to medication and behavioral recommendations presents a major challenge in managing these chronic conditions.
• Effective management strategies are crucial for CVD risk reduction.

Purpose of the Study:

• To describe the theoretical framework for a pharmacist-administered intervention targeting CVD risk reduction.
• To enhance medication adherence and improve health behaviors in patients with uncontrolled CVD risk factors.
• To investigate the efficacy of a tailored, theory-driven approach for managing hypertension and hyperlipidemia.

Main Methods:

• Adults with uncontrolled hypertension and/or hyperlipidemia were recruited from primary care clinics.
• Participants were randomized to a 1-year telephone-based intervention or usual care.
• The intervention, guided by theory, aimed to increase medication adherence and promote healthier behaviors.

Main Results:

• Enrollment commenced in November 2011 and is ongoing.
• The study targets a sample size of 500 patients.
• The Cardiovascular Intervention Improvement Telemedicine Study (CITIES) intervention is currently enrolling participants.

Conclusions:

• The CITIES intervention is built on a robust theoretical foundation.
• The intervention encourages home monitoring and tailored telephone support for patients with comorbidities.
• Clinical pharmacist-led telemedicine interventions show potential for efficient integration into primary care for CVD risk management.